SP-0256

N/A

Report date: 2026/05/13 09:07:44

Base Information

Drug NameSP-0256
Drug Alias NameRSV/hMPV mRNA VaccinehMPV/RSV mRNA VaccineRSV/hMPV mRNA LNP 1RSV/hMPV mRNA LNP 2RSV mRNA LNP CL 0137 +[11] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMetapneumovirus infectionsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoMexico +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi Pasteur
Inactive CompaniesN/A
Active IndicationsMetapneumovirus infectionsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A